LQLei Qiu

Lei Qiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lei Qiu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A feasibility study on predicting disease progression in high-grade gliomas using magnetic resonance imaging habitat radiomics based on response assessment in neuro-oncology (RANO) criteria

    by Yuchen Zhu, Gefei Jiang, Xingjian Sun, Lei Qiu, Kexin Shi, Mengxing Wu, Yinjiao Fei, Jinling Yuan, Jinyan Luo, Yurong Li, et al.

    Objective: Investigating progression risk insights of high-grade gliomas through habitat radiomics analysis. Methods: A cohort of 89 patients with high-grade gliomas was enrolled, with 63 patients in the train cohort and 26 patients in the test cohort. The methodology involved delineating the region of interest (ROI) within the tumor area on magnetic resonance imaging images, followed by multisequence registration. The ROI was further divided into subregions using K -means clustering. Radiomics features were extracted from the subregions, and feature selection was performed using least absolute shrinkage and selection operator regression. Four separate models were created: radiomics model, clinical model, habitat model, and combined model that merged the habitat signature with clinical factors. The accuracy of the models was evaluated using concordance index (C-index) and receiver operating characteristic analysis. Results: The ROI was divided into three subregions, from which 36 features were extracted and selected. The habitat model, radiomics model, clinical model, and combined model were constructed by combining the extracted features with clinical data. The habitat model showed excellent predictive performance with the C-index values of 0.879 in the train cohort and 0.781 in the test cohort. Using this model, patients were classified into high-risk and low-risk groups, resulting in significantly different median progression-free survival (mPFS) times of 7 and 31 months, respectively ( P < 0.001). Stratifying the patient cohort based on isocitrate dehydrogenase status also revealed distinct mPFS outcomes for high-risk and low-risk patients. Conclusion: The habitat model demonstrated outstanding predictive performance for forecasting the progression risk of patients with high-grade gliomas.

  • Open Access

    Development and validation of a machine learning model for predicting 3-year overall survival in metastatic nasopharyngeal carcinoma: a SEER database and web visualization study

    by Lei Qiu, Yinjiao Fei, Yuchen Zhu, Kexin Shi, Jinling Yuan, Gefei Jiang, Xingjian Sun, Yuandong Cao, Weilin Xu, Shu Zhou

    Background: Current prognostic models for metastatic nasopharyngeal carcinoma (M1-NPC) often employ oversimplified “catch-all” classifications that fail to account for the substantial heterogeneity in metastatic patterns and treatment responses. Furthermore, existing tools lack interactive visualization capabilities to support clinical decision-making. In this study, we aim to develop and validate a visual prognostic model for 3-year overall survival (OS) in M1-NPC patients. Methods: We retrospectively analyzed clinical and pathological data from M1-NPC patients in the Surveillance, Epidemiology, and End Results (SEER) database diagnosed between 2010 and 2021 with complete follow-up. Exclusion criteria included missing surgical resection data or undocumented metastatic sites. Patients were randomly allocated to training (70%) and testing (30%) cohorts. Using univariate Cox regression, we identified significant prognostic variables among 19 clinical factors. Five machine learning (ML) algorithms—support vector machine (SVM), random forest (RF), extreme gradient boosting (XGBoost), gradient boosting decision tree (GBDT), and k-nearest neighbor (KNN)—were developed and evaluated using the area under the receiver operating characteristic (ROC) curve (AUC), sensitivity, specificity, and accuracy metrics. The top 2 algorithms were combined to form an ensemble model. All six models were tested, with SHapley Additive exPlanations (SHAP) analysis applied for interpretability. The optimal model was implemented in an online calculator for 3-year OS prediction. Results: Among 19 candidate variables, univariate Cox regression identified 11 significant prognostic factors (PConclusions: Our validated RF-based model addresses a critical gap in M1-NPC prognostication, offering clinicians an interpretable tool for survival prediction. While limited by database constraints, this represents the first SEER-derived online calculator for M1-NPC with immediate clinical applicability.